John Smith
This is a multi-part message in MIME format.
------=_NextPart_000_0021_01C40173.7B23D830 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-
Encoding: quoted-printable
In the Paris paper today--The French authorities started testing today = on-file samples for the new
class of precurser steriods. They have = indicated that Lance Armstrong samples will be tested with
the new test = developed in America, by Sandos Labs. Results are expected in two weeks. =20 They had
asked Lance if he would send them a sample today, however Lance = evaded the issue by saying that he
is busy training, and making = commertials. ------=_NextPart_000_0021_01C40173.7B23D830 Content-
Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <HTML><HEAD> <META http-equiv=3DContent-
Type content=3D"text/html; = charset=3Diso-8859-1"> <META content=3D"MSHTML 6.00.2800.1400"
name=3DGENERATOR> <STYLE></STYLE> </HEAD> <BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2>In the Paris paper today--The French = authorities=20 started
testing today on-file samples for the new class of precurser = steriods.=20 They
have</FONT><FONT face=3DArial size=3D2> indicated that Lance = Armstrong samples=20 will be
tested with the new test developed in America, by Sandos=20 Labs.</FONT></DIV>
<DV><FONT face=3DArial size=3D2>Results are expected in two = weeks. =20 </FONT></DIV>
<DVI><FONT face=3DArial size=3D2>They had asked Lance if he = would send them a=20 sample
today, however Lance evaded the issue by saying that he is busy = training,=20 and making
commertials.</FONT></DIV></BODY></HTML>
------=_NextPart_000_0021_01C40173.7B23D830--
------=_NextPart_000_0021_01C40173.7B23D830 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-
Encoding: quoted-printable
In the Paris paper today--The French authorities started testing today = on-file samples for the new
class of precurser steriods. They have = indicated that Lance Armstrong samples will be tested with
the new test = developed in America, by Sandos Labs. Results are expected in two weeks. =20 They had
asked Lance if he would send them a sample today, however Lance = evaded the issue by saying that he
is busy training, and making = commertials. ------=_NextPart_000_0021_01C40173.7B23D830 Content-
Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> <HTML><HEAD> <META http-equiv=3DContent-
Type content=3D"text/html; = charset=3Diso-8859-1"> <META content=3D"MSHTML 6.00.2800.1400"
name=3DGENERATOR> <STYLE></STYLE> </HEAD> <BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2>In the Paris paper today--The French = authorities=20 started
testing today on-file samples for the new class of precurser = steriods.=20 They
have</FONT><FONT face=3DArial size=3D2> indicated that Lance = Armstrong samples=20 will be
tested with the new test developed in America, by Sandos=20 Labs.</FONT></DIV>
<DV><FONT face=3DArial size=3D2>Results are expected in two = weeks. =20 </FONT></DIV>
<DVI><FONT face=3DArial size=3D2>They had asked Lance if he = would send them a=20 sample
today, however Lance evaded the issue by saying that he is busy = training,=20 and making
commertials.</FONT></DIV></BODY></HTML>
------=_NextPart_000_0021_01C40173.7B23D830--

















